Helen Wheadon

2.1k total citations
53 papers, 1.6k citations indexed

About

Helen Wheadon is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Helen Wheadon has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 24 papers in Molecular Biology and 17 papers in Immunology. Recurrent topics in Helen Wheadon's work include Chronic Myeloid Leukemia Treatments (15 papers), Acute Myeloid Leukemia Research (14 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Helen Wheadon is often cited by papers focused on Chronic Myeloid Leukemia Treatments (15 papers), Acute Myeloid Leukemia Research (14 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Helen Wheadon collaborates with scholars based in United Kingdom, United States and Thailand. Helen Wheadon's co-authors include Melanie J. Welham, Nick Paling, Heather K. Bone, DC Linch, P B Boulos, Rosemary E. Gale, David C. Linch, Mhairi Copland, Edwina Dobbin and Tessa L. Holyoake and has published in prestigious journals such as The Lancet, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Helen Wheadon

47 papers receiving 1.5k citations

Peers

Countries citing papers authored by Helen Wheadon

Since Specialization

Citations

This map shows the geographic impact of Helen Wheadon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Wheadon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Wheadon more than expected).

Fields of papers citing papers by Helen Wheadon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Wheadon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Wheadon. The network helps show where Helen Wheadon may publish in the future.

Co-authorship network of co-authors of Helen Wheadon

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Wheadon. A scholar is included among the top collaborators of Helen Wheadon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Wheadon. Helen Wheadon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of current mouse in vivo models and advanced in vitro models for leukaemia research 2025 ·Blood Reviews ·(unknown), (unknown), Helen Wheadon	0
2	Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cells 2024 ·Nature Communications ·Hannah Donnelly, Ewan A. Ross, Yinbo Xiao, (unknown), (unknown), (unknown), Jennifer Cassels, Penelope M. Tsimbouri, Karen Dunn, Jodie Hay, Annie Cheng, R.M.D. Meek, Nikhil Jain, Christopher C. West, Helen Wheadon, Alison M. Michie, Bruno Péault, Adam G. West, Manuel Salmerón‐Sánchez, Matthew J. Dalby	7
3	Complexities of modeling the bone marrow microenvironment to facilitate hematopoietic research 2024 ·Experimental Hematology ·(unknown), (unknown), Helen Wheadon	7
4	Leukaemia Exposure Alters the Transcriptional Profile and Function of Macrophages in the Bone Marrow Niche 2023 ·Blood ·(unknown), (unknown), (unknown), Joana Bittencourt‐Silvestre, (unknown), Giovanny Rodriguez Blanco, Mary T. Scott, Karen Dunn, Vaidehi Krishnan, Mhairi Copland, David Vetrie, Ravi Bhatia, Seth B. Coffelt, S. Tiong Ong, Helen Wheadon, Sara Zanivan, Kristina Kirschner, G. Vignir Helgason	0
5	P1350: M2-LIKE MONOCYTE-DERIVED MACROPHAGES PROTECT AML CELL LINES AND PRIMARY AML CELLS AGAINST THERAPY-INDUCED APOPTOSIS 2023 ·HemaSphere ·(unknown), Αθανασία Παπαδοπούλου, Leandro Marcelo Martinez, Victoria Campbell, Carl S. Goodyear, Helen Wheadon, Mónica L. Guzmán, Mark Williams	0
6	BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia 2022 ·Cell Death Discovery ·(unknown), (unknown), (unknown), Jennifer Cassels, Alan Hair, G. Vignir Helgason, Helen Wheadon, Mhairi Copland	3
7	Using topic modeling to detect cellular crosstalk in scRNA-seq 2022 ·PLoS Computational Biology ·(unknown), Helen Wheadon, Simon Rogers, Thomas D. Otto	9
8	The application of BH3 mimetics in myeloid leukemias 2021 ·Cell Death and Disease ·(unknown), Helen Wheadon, Mhairi Copland	36
9	Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML 2021 ·Cell Death Discovery ·(unknown), Ya-Ching Hsieh, Daniella Zheleva, Sheelagh Frame, Helen Wheadon, Mhairi Copland	13
10	Correction to: Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML 2021 ·Cell Death Discovery ·(unknown), Ya-Ching Hsieh, Daniella Zheleva, Sheelagh Frame, Helen Wheadon, Mhairi Copland	1
11	Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy 2020 ·Leukemia ·Ross Kinstrie, Gillian A. Horne, Heather Morrison, David Irvine, Chinmay Munje, (unknown), (unknown), Karen Dunn, Jennifer Cassels, (unknown), (unknown), Mary T. Scott, Richard E. Clark, Tessa L. Holyoake, Helen Wheadon, Mhairi Copland	1
12	CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy 2020 ·Leukemia ·Ross Kinstrie, Gillian A. Horne, Heather Morrison, David Irvine, Chinmay Munje, (unknown), (unknown), Karen Dunn, Jennifer Cassels, (unknown), (unknown), Mary T. Scott, Richard E. Clark, Tessa L. Holyoake, Helen Wheadon, Mhairi Copland	50
13	Inhibition of NF-κB–Mediated Signaling by the Cyclin-Dependent Kinase Inhibitor CR8 Overcomes Prosurvival Stimuli to Induce Apoptosis in Chronic Lymphocytic Leukemia Cells 2013 ·Clinical Cancer Research ·Emilio Cosimo, Alison M. McCaig, (unknown), Helen Wheadon, (unknown), (unknown), Christian Berthou, Émilie Durieu, Nassima Oumata, Hervé Galons, Laurent Meijer, Alison M. Michie	28
14	Canonical Wnt Signaling Promotes Early Hematopoietic Progenitor Formation and Erythroid Specification during Embryonic Stem Cell Differentiation 2013 ·PLoS ONE ·Anuradha Tarafdar, Edwina Dobbin, (unknown), Robin Freeburn, Helen Wheadon	20
15	Differential Hox Expression in Murine Embryonic Stem Cell Models of Normal and Malignant Hematopoiesis 2010 ·Stem Cells and Development ·Helen Wheadon, Joanne M. Ramsey, Edwina Dobbin, Glenda J. Dickson, (unknown), Robin Freeburn, Alexander Thompson	12
16	Patterns of Wnt/Fzd/LRP Gene Expression During Embryonic Hematopoiesis 2008 ·Stem Cells and Development ·(unknown), Edwina Dobbin, Robin Freeburn, Helen Wheadon	41
17	Regulation of Embryonic Stem Cell Self-renewal by Phosphoinositide 3-Kinase-dependent Signaling 2004 ·Journal of Biological Chemistry ·Nick Paling, Helen Wheadon, Heather K. Bone, Melanie J. Welham	352
18	Changes in signal transduction downstream from the granulocyte-macrophage colony-stimulating factor receptor during differentiation of primary hemopoietic cells 1999 ·Experimental Hematology ·Helen Wheadon, Pamela Roberts, Michael Watts, David C. Linch	14
19	TISSUE-SPECIFICITY OF X-CHROMOSOME INACTIVATION PATTERNS 1993 ·UCL Discovery (University College London) ·(unknown), Helen Wheadon, (unknown), (unknown)	12
20	Frequency of clonal remission in acute myeloid leukaemia 1993 ·The Lancet ·Rosemary E. Gale, Helen Wheadon, Anthony H. Goldstone, D C Linch, (unknown)	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact